Oncosil Medical (ASX:OSL) Shares Down 2.8%

Oncosil Medical Ltd (ASX:OSL)’s share price was down 2.8% during mid-day trading on Friday . The stock traded as low as A$0.18 ($0.12) and last traded at A$0.18 ($0.12), approximately 1,257,166 shares traded hands during trading. The stock had previously closed at A$0.18 ($0.13).

The firm has a market capitalization of $88.30 million and a price-to-earnings ratio of -12.50. The company has a current ratio of 11.69, a quick ratio of 11.59 and a debt-to-equity ratio of 0.45. The company has a fifty day moving average price of A$0.12 and a 200-day moving average price of A$0.08.

Oncosil Medical Company Profile (ASX:OSL)

OncoSil Medical Limited, a medical device company, focuses on the development of localized treatments for cancer in Australia. Its lead product is OncoSil, a brachytherapy device comprising OncoSil Phosphorous-32 Microparticles and OncoSil Diluent, which implants a pre-determined dose of beta radiation emitting isotope directly into cancerous tissue for the treatment of pancreatic and liver cancer.

Recommended Story: Is the QQQ ETF safe?

Receive News & Ratings for Oncosil Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncosil Medical and related companies with MarketBeat.com's FREE daily email newsletter.